Tag Archives: a

Actos Bladder Cancer Update

Following an FDA safety warning issued in June 2011, a number of Actos users have filed injury claims against the drug’s manufacturer Takeda Pharmaceuticals, alleging that the popular Type 2 diabetes medication caused serious complications, including bladder cancer. Nadrich & Cohen, LLP is committed to providing concerned Actos users with the latest news and updates […]

Read More »